Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22N2O |
InChIKeyCZQRBMMDXCQOPX-UHFFFAOYSA-N |
CAS Registry2941356-54-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nervous System Diseases | Preclinical | United States | 19 Jun 2025 |





